Trial intelligence / Profile preview

Sevoflurane via Anaconda in Post-operative Head & Neck Surgery

NCT03559920Completed

Sponsor
Yonsei University
Start
Apr 2018
Primary completion
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of sevoflurane (2 arms), sponsored by Yonsei University. Primary endpoint: Optimal end-tidal sevoflurane concentration at 30 minutes. Started Apr 2018; status: completed.

02

Drugs

sevoflurane

Beyond the preview

Go deeper on NCT03559920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03559920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call